Christie 55 Solutions LLC

In a new op-ed for Real Clear Energy, Governor Chris Christie analyzes the ongoing delays in?rebuilding Puerto Rico’s electric grid after Hurricane Maria and the critical role of the federally appointed Puerto Rico Financial Oversight and Management Board (Oversight?Board) in the ongoing bankruptcy of the Puerto Rico Electric Power Authority?(PREPA) that is a significant impediment to rebuilding?Puerto Rico's energy infrastructure?for the future. Governor Christie praised Puerto Rico's new Governor?Jenniffer?Gonzalez-Colon for having "already taken important and positive steps and demonstrating her readiness to take bold action to ensure that the Island's businesses and residents have reliable, secure electricity."?He encouraged the Oversight Board to complete PREPA's restructuring, end the bankruptcy, and allow Puerto Rico and its economy to move?forward. Read the full op-ed below ?? https://lnkd.in/ezQPeNGM

Join the Rutgers Business School Lerner Center for the Study of Pharmaceutical Management Issues for its annual healthcare symposium, “Value, Promise, and Challenges of the Biopharmaceutical Industry” on April 16 at the Rutgers Business School in Newark. The event will feature a keynote from Ron Cohen, M.D., founder and former CEO of Acorda Therapeutics, followed by a panel discussion moderated by Cole Werble, former publisher of the FDC Reports. Panelists include Peter Pitts, Kirsten Axelsen, and Richard Bagger of Christie 55 Solutions – who will share their insights about leadership in the life sciences. Learn more, and register today ?? https://lnkd.in/eUuEsMqy

In a recent thought piece – “One Fix CMS Can Make to the IRA Right Now” – Jaden Jackson and Rich Bagger of Christie 55 Solutions emphasize a significant flaw in the Inflation Reduction Act’s Medicare drug price “negotiation” program that CMS can remedy without delay. If CMS imposes price controls on innovator drugs near to or in some cases after they lose exclusivity, it would discourage the launch of low-cost generics, hurting competition, and increasing long-term costs. A simple fix: CMS should exclude from the price setting process drugs that are near their loss of exclusivity date. This small change can preserve the Hatch-Waxman framework and ensure patients continue to benefit from robust generic competition after the innovators’ patents expire. Read the full piece below ?? https://lnkd.in/eYYWTcBt

Panel #1: Saving Lives Around the World by Finding Cures in New Jersey is starting now, featuring Moderator Richard Bagger of Christie 55 Solutions LLC and panelists David Perlin, PhD of Hackensack Meridian Health Center for Discovery and Innovation , Patrick Collins of NORD, Ric Timmers of Bayer | Consumer Health and HINJ’s own Chrissy Buteas. #HINJLifeSciencesSummit25

On ABC's "This Week," Governor Chris Christie discussed the recent meeting between President Donald Trump and Ukrainian President Volodymyr Zelenskyy. Governor Christie expressed concern that President Trump's words and actions increasingly align with Russian interests, stating that he "looks like and sounds like an ally of Putin." Watch here: https://lnkd.in/dTdK5ChN

Join the Rutgers Business School Lerner Center for the Study of Pharmaceutical Management Issues Annual Symposium "Value, Promise and Challenges of the Biopharmaceutical Industry" at Rutgers Business School in Newark on April 16, 2025. The event will be keynoted by Ron Cohen, M.D., Founder, Former Chair and CEO of Acorda Therapeutics, followed by a panel moderated by Cole Werble, with Kirsten Axelsen, Peter Pitts and me. https://lnkd.in/g_FjvRS5

Last month, Governor Chris Christie sat down with Jon Stewart for a candid conversation about the start of President Trump’s second term, the failed Harris campaign, the controversy surrounding Project 2025, and the GOP’s ongoing identity crisis. Drawing from his firsthand experiences with the President, Governor Christie offered sharp insights into the political and legal challenges ahead for both the Republican Party and the nation. Watch the full episode here??? https://lnkd.in/e9YchDAr

Last week, Governor Chris Christie spoke at the Principles First Summit, where he joined a panel analyzing President Trump’s first month back in office and debating the future of the Republican Party. Governor Christie offered his take on President Trump’s early decisions, the party’s evolving identity, and the need for principled leadership that prioritizes results over rhetoric. The discussion explored whether the GOP should return to its conservative roots versus staying on its current path. Watch the full discussion here??? ?https://lnkd.in/ea8542Nz

In an op-ed for The Free Press, Governor Christie breaks down the legal implications of the government's motion to dismiss the prosecution of New York City Mayor Eric Adams. “In my seven years as the United States Attorney for the District of New Jersey, we brought 130 cases of political corruption. Though I have been a lifelong Republican, corruption has no party—the cases were against Republicans and Democrats alike.” “The reason those cases were so important was that it showed citizens that betrayal of the public trust would not be tolerated and could not be fixed or explained away. Our ability to govern ourselves, the very basis of our civilized society, could not survive for very long without that belief.” Read the full op-ed below??? https://lnkd.in/e7_mjdHa

As noted in a LinkedIn post by Christie 55 Solutions Partner Richard Bagger, only half of the money spent on prescription drugs goes to the companies that discover, develop, and manufacture them. So, where does the other half go? A new study by the Berkeley Research Group answers that question with eye-opening implications for public policy, shedding light on the role of intermediaries and how they impact the cost of medicines for patients without contributing anything to research and development or manufacturing them. Read the full study from the Berkeley Research Group here: https://lnkd.in/gZSwZwCd